Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Sep 1, 2021 (5 years ago)

Hydroquinone

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Subpotency: one product for active ingredient assay and another one for preservative assay

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Hydroquinone, USP, 4% Skin Bleaching Cream, packaged in 1 oz (28.35g) tube, Rx only, Manufactured for: Westminster Pharmaceuticals, LLC Nashville, TN 37217, NDC 69367-174-01 UPC 3 69367 17401 5

Affected NDC 69367-0174-01

Compare with the code on your package — it is the most precise check available.

Drug: Hydroquinone

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Hydroquinone
NDC 69367-0174
40 mg/g Cream
Topical
Westminster Pharmaceuticals, LLC Rx
Recalling firm
Monarch PCM, LLC
NDC code
69367-174-01
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0818-2021 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Hydroquinone recalls

See all
Class II · Moderate risk

Hydroquinone USP

Finished product specification did not meet USP specifications.

Terminated Other Monarch PCM, LLC NDC 69367-174-01 D-0855-2021
Class II · Moderate risk

Dermanak original crema blanqueador

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-108-02 D-1500-2019

Other recalls by Monarch PCM, LLC

All 2021 recalls
Class III · Low risk

Phenobarbital Elixir

Does Not Meet USP or OTC Monograph: Product exceeds USP specification for alcohol content

Terminated Unapproved drug Monarch PCM, LLC NDC 69367-172-16 D-0878-2022
Class II · Moderate risk

Hydroquinone USP

Finished product specification did not meet USP specifications.

Terminated Other Monarch PCM, LLC NDC 69367-174-01 D-0855-2021
Class III · Low risk

Sodium Sulfacetamide

Subpotency: one product for active ingredient assay and another one for preservative assay

Terminated Wrong potency / content Monarch PCM, LLC NDC 42808-103-06 D-0817-2021